Literature DB >> 34007313

Prognostic value of microRNA-378 in esophageal cancer and its regulatory effect on tumor progression.

Wei Jin1, Lixin Wang2, Sujie Cheng3, Hongmei Lv4.   

Abstract

The incidence and mortality rates of esophageal squamous cell carcinoma (ESCC) are high in China, which has increased the clinical and economic burden. The present study aimed to investigate the role of microRNA (miRNA/miR)-378 in ESCC. Reverse transcription-quantitative polymerase chain reaction analysis was performed to detect miR-378 expression in ESCC tissues and cell lines. Survival analysis was performed using the Kaplan-Meier method, while Cox regression analysis was performed to determine the prognostic value of miR-378 in ESCC. miR-378 mimic and miR-378 inhibitor was transfected into ESCC cells to overexpress or knockdown miR-378 expression levels in ESCC cells. The Cell Counting Kit-8 assay was performed to assess the proliferative ability of ESCC cells, while the Transwell assay was conducted to assess the effect of miR-378 on the migratory and invasive abilities of ESCC cells. The results demonstrated that miR-378 displayed significantly lower expression both in ESCC cells and tissues by comparison with those in normal cells and adjacent tissues. In addition, patients with low miR-378 expression had a worse prognosis and a shorter overall survival time than those with high miR-378 expression. Furthermore, low miR-378 expression promoted ESCC cell proliferation, migration and invasion. Taken together, the results of the present study suggest that miR-378 may act as a tumor suppressor in the occurrence and development of ESCC.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  esophageal cancer; microRNA-378; prognostic value; progression

Year:  2021        PMID: 34007313      PMCID: PMC8120653          DOI: 10.3892/etm.2021.10136

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

1.  MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.

Authors:  Zhi Cui; Shiqun Sun; Qilin Liu; Xuechun Zhou; Siyu Gao; Peixuan Peng; Qianpeng Li
Journal:  Biochem Cell Biol       Date:  2019-07-02       Impact factor: 3.626

Review 2.  Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy.

Authors:  Hidekazu Hirano; Ken Kato
Journal:  Jpn J Clin Oncol       Date:  2019-05-01       Impact factor: 3.019

Review 3.  Circulating miRNA profiling to identify biomarkers of dysmetabolism.

Authors:  Sara Tomaselli; Nadia Panera; Angela Gallo; Anna Alisi
Journal:  Biomark Med       Date:  2012-12       Impact factor: 2.851

Review 4.  Exploring miRNA based approaches in cancer diagnostics and therapeutics.

Authors:  Shivangi Mishra; Tanuja Yadav; Vibha Rani
Journal:  Crit Rev Oncol Hematol       Date:  2015-10-08       Impact factor: 6.312

Review 5.  Screening for esophageal squamous cell carcinoma: recent advances.

Authors:  Don C Codipilly; Yi Qin; Sanford M Dawsey; John Kisiel; Mark Topazian; David Ahlquist; Prasad G Iyer
Journal:  Gastrointest Endosc       Date:  2018-04-27       Impact factor: 9.427

6.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 7.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

8.  Identification of potential key genes in esophageal adenocarcinoma using bioinformatics.

Authors:  Zhiyu Dong; Junwen Wang; Haiqin Zhang; Tingting Zhan; Ying Chen; Shuchang Xu
Journal:  Exp Ther Med       Date:  2019-09-05       Impact factor: 2.447

9.  miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.

Authors:  Xiangyu Su; Chanchan Gao; Xiaoyao Feng; Ming Jiang
Journal:  Exp Ther Med       Date:  2020-02-21       Impact factor: 2.447

10.  MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer.

Authors:  Guang-Jun Zhang; He Zhou; Hua-Xu Xiao; Yu Li; Tong Zhou
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.